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CMS Hospital Inpatient Quality Reporting Program 
Hospitals participating in the Centers for Medicare & Medicaid Services 
(CMS) Inpatient Prospective Payment System (IPPS) Hospital Inpatient 
Quality Reporting Program, formerly known as Reporting Hospital Quality 
Data for Annual Payment Update (RHQDAPU), will soon be required to 
submit healthcare-associated infections (HAI) data via NHSN. Specifically, 
hospitals are required to report central line-associated bloodstream infection (CLABSI) events col-
lected in accordance with the NHSN Patient Safety Component protocol for all adult and pediatric 
intensive care units (ICUs) and level II/III and level III neonatal intensive care units (NICUs) that 
occur on or after January 1, 2011, in order to receive the Fiscal Year (FY) 2013 payment. The 
NHSN team recommends review of the CLABSI Protocols and Facility Start-up trainings to refresh 
knowledge on how to report CLABSIs and adding locations and users. 
NHSN Purposes and Confidentiality Assurance Changes 
When your facility enrolled in NHSN, the primary contacts and an executive of the facility’s leader-
ship (e.g., CEO) signed a consent form agreeing to abide by the requirements of NHSN. For CDC’s 
part, we extended an Assurance of Confidentiality which protected your data from disclosure with-
out your permission and prohibited us from using your data for any reason other than the stated 
purposes of the data collection.  Because of the increasing number of states with mandatory HAI 
reporting that are engaged in HAI prevention activities, and because of CMS’ pay-for-reporting 
program (see article above) and the potential for federal HAI reporting mandates, we have added 
the four new purposes listed below to the existing six purposes of NHSN:   
Comply with legal requirements – including but not limited to state or federal laws, regula-
tions, or other requirements – for mandatory reporting of healthcare facility-specific adverse 
event, prevention practice adherence, and other public health data. 
Enable healthcare facilities to report HAI and prevention practice adherence data via NHSN to 
the U.S. Center for Medicare and Medicaid Services (CMS) in fulfillment of CMS’s quality meas-
urement reporting requirements for those data. 
Provide state departments of health with information that identifies the healthcare facilities in 
their state that participate in NHSN.  
Provide to state agencies, at their request, facility-specific, NHSN patient safety component 
and healthcare personnel safety component adverse event and prevention practice adherence 
data for surveillance, prevention, or mandatory public reporting. 
These new purposes necessitated a modification of the Assurance of Confidentiality statement, 
such that it will now protect only information voluntarily provided.  All facilities will be required to 
read, sign, and return the updated NHSN Agreement to Participate and Consent document in order 
to continue participating in NHSN. 
These changes will take effect for newly enrolling facilities with the 6.3 release of NHSN, scheduled 
for October 28.  For existing NHSN facilities, the changes will take effect after December 15. NHSN 
Facility Administrators will be emailed further instructions for submission of the updated consent 
and will receive an alert upon login to the NHSN application that the updated NHSN Agreement to 
Participate and Consent is available for printing. 
Inside this issue: 
NHSN Vaccination Module Update 2 
Assuring the Quality of NHSN Data 2 
NICU Survey     3 
NHSN Application Updates 4 




NHSN e -News 
NHSN Vaccination  Module Update 
The NHSN High Risk Inpatient Influenza Vaccination (HRIIV) Module has been updated and renamed the Vacci-
nation Module to reflect the recommendations of the Advisory Committee on Immunization Practices (ACIP) for 
the 2010-2011 influenza season. The 2010-2011 seasonal vaccine contains the following strains: 
A California/ 7/ 09 (H1N1)-like virus (pandemic (H1N1) 2009 influenza virus 
A/Perth / 16/ 2009 (H3N2)- like virus 
B/Brisbane/ 60/ 2008-like virus  
 
Only one annual vaccine will be required to be administered to protect against the expected influenza strains this year and are repre-
sentative of influenza viruses predicted to be circulating in the United States during the current influenza season.  This includes the 
pandemic H1N1 influenza strain. There have been some changes to recommendations for who should receive seasonal vaccination; 
for example there is a newly approved vaccine for the elderly and additional recommendations for the type of vaccine used in chil-
dren ≤ 8 years.  For complete information, see http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5908a1.htm. 
Assuring the Quality of NHSN Data 
In the August, 2009 NHSN Newsletter(http://www.cdc.gov/nhsn/PDFs/Newsletters/
NHSN_Newsletter_Aug09.pdf), we told you about efforts being undertaken to assure that the 
NHSN aggregate data are as accurate as possible.  
From time to time we will share information with you regarding those efforts and the findings in 
the hopes that it might assist you in reporting high quality data.   
One such effort is a review of SSI data for the periods between January 1, 2006–May 30, 2009. 
In this project, we identified facilities with procedure-specific, risk-stratified surgical site infection 
(SSI) rates > 50% to determine the validity of the data and to correct any erroneous data. Communications were made to 199 facili-
ties by email and telephone calls. It was determined that the data were correct in 104 (53%) of the facilities. Two facilities were un-
able to be contacted, as they had closed. Of the remaining 93 facilities, 90 (97%) had missing procedure data. These facilities opted 
to either enter the missing data or remove SSI surveillance from the facility’s monthly reporting plan for the involved months, thereby 
removing these data from the NHSN database.  
Summary: While these procedures represent a small percentage of the total NHSN aggregate SSI data, it is still important to verify 
that the data being entered are accurate and complete. Some NHSN users stated that they did not understand that participation in 
the Procedure-associated Module required that ALL procedures performed for a given NHSN operative procedure category under sur-
veillance , e.g., Coronary artery bypass graft (CBGB), be entered, not just those that developed SSIs.  If you are participating in this 
module, please verify that you are including all appropriate procedures and that these data are being imported into NHSN.  Watch for 
more information about quality assurance projects in upcoming newsletters. And as always, thank you for your efforts to make the 
NHSN data the best they can be!   
NHSN Case Studies Offer Opportunity to Hone Surveillance Skills 
The American Journal of Infection Control (AJIC) and the National Healthcare Safety Network (NHSN) are continuing the series of 
case studies in AJIC that began in June 2010. These cases reflect some of the complex patient scenarios that infection preventionists 
have encountered in their daily surveillance of healthcare-associated infections (HAIs) when using the NHSN definitions. With each 
case, a link to an online survey is provided where you can answer the questions and receive immediate feedback in the form of an-
swers and explanations. All individual participant answers are confidential, although it is the authors’ hope to share a summary of the 
findings at a later date. All cases, answers, and explanations have been reviewed and approved by the NHSN staff.  
The second and third case studies are published in AJIC’s September and October 2010 issues, respectively, and are available online 
at http://www.surveymonkey.com/s/AJIC-NHSN-Case2 (for Case study #2) and http://www.surveymonkey.com/s/AJIC-NHSN-Case3 
(for Case Study 3).  
 
 




NICU Survey  
CDC’s Division of Healthcare Quality Promotion (DHQP) is conducting a survey of NHSN facilities that report data from their neonatal 
intensive care units (NICUs). The NICU has a unique population of patients who are particularly vulnerable to acquiring healthcare-
associated infections (HAI). The incidence of HAIs reported from NICUs, especially central line-associated bloodstream infection 
(CLABSI) rates among very low birthweight infants, are consistently among the highest reported. Additionally, the epidemiology of 
pathogens associated with these infections is changing in concerning ways: for example, significant increases in the incidence of me-
thicillin-resistant Staphylococcus aureus (MRSA) infections and a growing proportion of infections caused by Enterococcus, Candida 
spp, and Gram-negative bacilli are being observed among NICU patients.  Although the published literature describes studies and 
strategies for prevention of HAIs, these are targeted mainly at adult populations, and NICU-specific infection prevention guidelines are 
lacking. Consequently, variations in HAI prevention practices exist.   
The survey will address surveillance methods and prevention strategies in NICUs. A web-based questionnaire will be distributed to 
NHSN facilities that report NICU data. The objectives of the survey are to 1) to conduct a multicenter assessment of HAI prevention 
strategies in NICUs, including CLABSI and MRSA infection prevention and 2) to assess the understanding of NHSN reporting  and defi-
nition requirements specific to NICU populations (i.e., umbilical central line reporting methods, early onset sepsis reporting). Results 
of the survey will aid in implementing any modifications in the NHSN methodology to improve surveillance efforts, as well as help us 
understand the impact NICU-specific infection prevention guidelines in development.  
Update on Antimicrobial Use and Resistance (AUR) Module   
The purpose of the Antimicrobial Use and Resistance (AUR) Module is to provide a mechanism for facilities to report and analyze an-
timicrobial use and/or resistance as part of antimicrobial stewardship efforts at their facility.  This module, which contains two options, 
was suspended in 2010 in order to retool it as an electronic data import module only. The Pharmacy Option focuses on antimicrobial 
usage, and the Microbiology Option focuses on antimicrobial resistance.  In order to participate in either option, the facility will have 
to coordinate with their facility’s providers of pharmacy and microbiology software to configure their systems to enable the generation 
of standard formatted file(s) to be imported into NHSN.  The format provided for data submission follows the Health Level Seven 
(HL7) Clinical Document Architecture (CDA).  Manual data entry will not be available for the new AUR Module.   
AUR Pharmacy Option 
Anticipated launch early 2011 
Antimicrobial usage will be electronically captured from electronic medication administration record (eMAR) and/or bar cod-
ing medication administration (BCMA) systems 
If you would like to participate in this module and if you have eMAR/BCMA, please let your vendor know that you want them 
to enable their software to support this surveillance  
AUR Microbiology Option 
Anticipated launch early 2012 
SAMS Update   
Many of you have become aware of the intent of NHSN to replace the digital certificate with another means of user authentica-
tion.   The NHSN team will start an internal pilot of the secure access management services (SAMS) system in the fourth quarter of 
2010 and an external SAMS pilot is planned between the first and second quarters of 2011, with mass migration to follow. In the 
meantime, you should not delay enrolling in NHSN or renewing a soon-to-expire digital certificate because of the pending new au-









NHSN Application Updates 
The newest version of NHSN, version 6.3, was released on October 28th, 2010. Please read the notes be-
low regarding a few important enhancements in this version.  




Confer Rights to Facility Identifiers: Facilities can now choose whether to confer rights to 
all of their facility identifiers, such as Facility Name, City, State. Note that only those fa-
cilities who no longer wish to share facility identifiers with a particular group will need to 
update their conferred rights. 
Printable List of Locations: Facilities can now print a list of all locations set-up in their 
facility in NHSN. This includes both active and inactive locations. Go to Facility > Loca-
tions. Click “Find.” Above the Locations Table, click “Print Location List.”  
Patient Safety  
Component: 
Standardized Infection Ratios (SIRs): SIRs have been added for CLABSI data. In addition, 
new SIRs have replaced all SSI rates. For details, please review the NHSN Newsletter 
Special Edition: Your Guide to the SIR, available at: NHSN e-News: SIRS Special Edition 
newsletter. 
Statistics Calculator: A statistics calculator has been added as an option on the nav bar 
(under Analysis). This is a tool that was used in the legacy NNIS system and provides 
functionality for a user to compare two proportions, two SIRs, two incidence density 
rates, or compare an SIR to 1. 
Printable List of Surgeons: Facilities can now print a list of all surgeons set-up in their 
facility in NHSN. This includes both active and inactive surgeons. Go to Facility > Sur-
geons. Click “Find.” Above the Locations Table, click “Print Surgeon List.” 
Healthcare Personnel 
Safety Component: 
 An Analysis Output Option has been added that will create an OSHA 300 log for Blood/Body 
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                   NHSN Questions & Answers    
Q:  Are non-absorbable 
sutures and surgical staples 
considered implants in 
NHSN?  
A:  Non-absorbable sutures are not 
considered implants, but staples are. 
Q:  When patients are admitted to an 
inpatient unit with a permanent 
(tunneled) pre-existing central line in 
place, which is not accessed during the 
hospitalization, are those days included 
in the central line-day count? 
A:  Permanent central lines should be 
included in the central line-day count 
beginning on the first day that they are 
accessed and continuing until the pa-
tient is discharged or the line is discon-
tinued, whichever comes first.  There-
fore, if a patient is admitted with a per-
manent central line which is not ac-
cessed until hospital day 4, then the 
line should not be included in the line-
days count until day 4 and then in-
cluded every day until the patient is 
discharged or the line is discontinued. 
Q:  Is a fall considered “trauma” when 
completing the Denominator for Proce-
dure form for surgical site infection 
surveillance? 
A:  Yes, trauma is defined in NHSN as 
“blunt or penetrating traumatic injury.”   
Therefore, if the surgery was performed 
because of a fall, for example, a hip 
arthroplasty following a fall, then indi-
cate “yes” for the trauma field. 
Q:  The central line-associated blood-
stream infection protocol states that 
“Ideally, blood specimens should be 
obtained from two to four blood draws 
from separate venipuncture sites…not 
through a vascular catheter….If your 
facility does not currently obtain speci-
mens using this technique, you may still 
report BSIs using the criteria and notes 
above but you should work with appropri-
ate personnel to facilitate better specimen 
collection practices…”  Does this mean that 
I have a choice whether or not to utilize 
positive blood cultures obtained through a 
vascular access device in my BSI surveil-
lance? 
A:  No.  Blood cultures collected by any 
means, either through venipuncture or 
collected through existing vascular cathe-
ters must be considered in your surveil-
lance of BSI.    
Did you know about…? 
1 NHSN Expansion! The NHSN team continues to undergo record growth having 
enrolled 340 new facilities in the last 60 days. Because of this 
increase, though we continue to strive to respond in as timely a 
manner as possible, it may take us a little more time to respond 
to your questions than it has in the past.  To this end, we have 
recently added new staff members.  Unfortunately, some NHSN 
users are sending the same question more than once in the hopes 
of getting a faster response.  Doing so will not hasten our re-
sponse but instead slow the system by clogging the mailbox.  Of 
course, if you have not received a response within a week, please 
send an inquiry to the mailbox. Your cooperation is greatly appre-
ciated.  As a quick reminder, please remember that inquiries/
questions should initially be sent via email to nhsn@cdc.gov.  
2 New NHSN Team Members! The NHSN Training and User Support team has recently 
added two new staff members to provide support to NHSN 
users. Henrietta Smith joins the team as a NHSN nurse con-
sultant.  She previously worked at WellStar Windy Hill Long-
term Acute Care Hospital and WellStar Cobb Hospital both in 
Georgia. In addition,  Amber Craggette provides NHSN help 
desk support. Recently, Amber moved from Virginia where she 
worked as a customer support representative at Military Dis-
tributors of Virginia.   
The Centers  for  D isease Contro l  
and Prevention  (CDC)  
MS-A24 
1600 Clifton Rd 
Atlanta, GA 30333  
Email: nhsn@cdc.gov 
CDC's NHSN Web site:  www.cdc.gov/nhsn 
The National Healthcare Safety Network (NHSN) is a voluntary, secure, inter-
net-based surveillance system that integrates patient and healthcare person-
nel safety surveillance systems managed by the Division of Healthcare Qual-
ity Promotion (DHQP) at CDC. 
During 2008, enrollment in NHSN was opened to all types of healthcare facili-
ties in the United States, including acute care hospitals, long-term acute care 
hospitals, psychiatric hospitals, rehabilitation hospitals, outpatient dialysis 
centers, ambulatory surgery centers, and long term care facilities. 
 
 
